Viral & Non-Viral Vector Manufacturing Market to be dominated by Growing R&D Activities through 2027
Rising prevalence of fatal
diseases to drive the viral & non-viral vector manufacturing market in the
forecast period, 2023-2027.
According to TechSci Research report, “Viral
& Non-Viral Vector Manufacturing Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global viral & non-viral vector
manufacturing market is anticipated to grow at a significant rate in the forecast
period, 2023-2027. The growing prominence of gene and cell therapy products and
rising incidences of genetic disorders, cancers, and infectious diseases are
the primary factors driving the demand for the global viral & non-viral
vector manufacturing market. Growing technological advancements, increasing
number of clinical studies, and rising funding activities driving research
related to vector-based therapies are expected to influence the market demand. Also,
the robust pipeline of gene and cell therapy products along with vector-based
vaccines, are increasing the growth of the market, globally.
However, the high cost of vector manufacturing,
low transfection efficiency, and complications associated with large-scale
production of viral and non-viral vectors may likely hamper the growth of the
global viral & non-viral vector manufacturing market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Viral & Non-Viral Vector Manufacturing Market"
The global viral &
non-viral vector manufacturing market is segmented into vector type,
indication, application, and company.
Based on vector type, the
market is segmented into viral vector and non-viral vector. Based on viral
vector, the market is further segmented into adenoviral vector, retroviral
vector, lentiviral vector, vaccinia viral vector, and others. Based on non-viral
vector, the market is further segmented into plasmid DNA, lipid-based non-viral
vector, polymer-based non-viral vector, and others. The non-viral vector segment
is expected to witness the significant growth in the upcoming years. This is because
it is used in vaccine development.
Based on indication, the
market is divided into cancer, genetic disease, infectious disease,
cardiovascular diseases, and others. The cancer sub-segment is expected to hold
the considerable market share. This is due to the rising incidences of cancer,
and large patient pool.
Based on application, the
market is divided into gene therapy, vaccinology, cell therapy, and others. The vaccinology segment is
expected to witness largest market share. This is attributed the regular use of
viral vector in vaccine development due to their efficiency benefits.
Major companies operating
in global viral & non-viral vector manufacturing market are:
- Catalent, Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- Genscript Biotech Corporation
- Lonza Group AG
- Merck KGaA Inc.
- Oxford Biomedica plc
- Sartorius AG
- Takara Bio Inc.
- Thermo Fisher Scientific Inc
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the market in 2021 and is expected to maintain
its dominance in the coming years due to its sophisticated healthcare services
and elevated cancer prevalence rate. The increasing number of company collaborations, heavy investments in R&D, growing urbanization, presence of a
significant number of research centers, and advancement in technology are propelling
the market growth. Also, increasing R&D activities in vector-based therapy
innovations in the region are expected to propel the global viral &
non-viral vector manufacturing market growth till 2027” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“Viral & Non-Viral
Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027 Segmented By Vector Type (Viral Vector v/s Non-Viral
Vector), By Indication (Cancer, Genetic Disease, Infectious Disease,
Cardiovascular Diseases, Others), By Application (Gene Therapy, Vaccinology,
Cell Therapy, Others), By Company and By Region”, has evaluated the future growth
potential of global viral & non-viral vector manufacturing market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global viral & non-viral vector
manufacturing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com